Evaluation of Surfactant Function: In Vitro and In Vivo Techniques in Experimental Respirology

Open access

Evaluation of Surfactant Function: In Vitro and In Vivo Techniques in Experimental Respirology

Pulmonary surfactant is present as the thin film of surface active material in the terminal airspaces and conducting airways. The major function of the surfactant film is to reduce the surface tension at the alveolar surface. Deficiency or dysfunction of pulmonary surfactant cause severe respiratory diseases that make the study of pulmonary surfactant not only of physiological but also of clinical importance.

There are three main categories of methods for assessing the properties of pulmonary surfactant: in vitro, in situ and in vivo techniques. Pulsating bubble surfactometer (PBS) and captive bubble surfactometer (CBS) enables to study surfactant properties at spherical air-liquid interphase. Capillary surfactometer in contrast to alveolar models mimics the human terminal airways and evaluates surface properties required for airway patency. Each of above-mentioned methods enables to study exogenous surfactants, as well as surface activity of lavage fluids or tracheal aspirates.

Biophysical characteristics should be reflected by lung compliance and, as a consequence, by improved blood oxygenation. Various animal models have been developed to evaluate the efficacy of surfactant replacement therapy on preterm and term animals. In vivo models can be divided in those, primarily involving surfactant deficiency, such as premature animal model, and those with secondary surfactant dysfunction or inactivation, such as meconium or acid aspiration models.

This review is restricted to the in vivo and in vitro techniques handled by the authors in their research performed within the last years at both domestic and external laboratories.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Robertson B Schurch S. Assessment of surfactant function. In: Uhlig S Taylor AE editors. Methods in pulmonary research. Basel-Boston-Berlin: Birkhäser Verlag; 1998. p. 349 - 83.

  • Enhorning G. Pulsating bubble technique for evaluating pulmonary surfactant. J Appl Physiol 1977; 43: 198-203.

  • Calkovska A Some M Linderholm B Johansson J Curstedt T Robertson B. Biophysical and physiological properties of porcine surfactant enriched with polymyxin B. Biol Neonate 2005; 88: 101-8.

  • Schürch S Bachofen H Goerke J Possmayer F. A captive bubble method reproduces the in situ behavior of lung surfactant monolayers. J Appl Physiol 1989; 67: 2389 - 96.

  • Calkovska A Linderholm B Haegerstrand - Bjökman M Curstedt T. Fibrinogen counteracts inactivation of lung surfactant by surface area cycling. Neonatology 2010; 97(4): 398-9.

  • Schoel WM Schurch S Goerke J. The captive bubble method for the evaluation of pulmonary surfactant: surface tension area and volume calculations. Biochim Biophys Acta 1994; 1200(3): 281 - 90.

  • Lema G Enhorning G. Surface properties after a simulated PLA2 hydrolysis of pulmonary surfactant's main component DPPC. Biochim Biophys Acta 1997; 1345(1): 86-92.

  • Mokra D Tribulova E Saffova I Erneyova J Calkovska A. Changes in surface activity of surfactant induced by in vitro exposure to meconium assessed by capillary surfactometer. Acta Med Mart 2010; 10(3): 13-18

  • Lewis JF Veldhuizen RA. Factors influencing efficacy of exogenous surfactant in acute lung injury. Biol Neonate 1995; 67: 48-60.

  • Robertson B. Animal models of neonatal surfactant dysfunction. In: Robertson B van Golde LMG Batenburg JJ editors. Pulmonary surfactant. From molecular biology to clinical practice. Amsterdam London New York Tokyo: Elsevier 1992. p. 459 - 84.

  • Calkovska A Some M Linderholm B Curstedt T Robertson B. Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin. Pulm Pharmacol Ther 2008; 21(2): 393-400.

  • Enhörning G Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972; 50: 58-66.

  • Fujiwara T Maeta H Chida S Morita T Watabe Y Abe T. Artificial surfactant therapy in hyalinemembrane disease. Lancet 1980; 1: 55-9.

  • Sun B Curstedt T Song GW Robertson B. Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate 1993; 63: 96-104.

  • Herting E Jarstrand C Rasool O Curstedt T Sun B Robertson B. Experimental neonatal group B streptococcal pneumonia: effect of a modified porcine surfactant on bacterial proliferation in ventilated near-term rabbits. Pediatr Res 1994; 36(6): 784-91.

  • Stichtenoth G Linderholm B Björkman MH Walter G Curstedt T Herting E. Prophylactic intratracheal polymyxin B/surfactant prevents bacterial growth in neonatal E. coli pneumonia of rabbits. Pediatr Res 2009; [Epub ahead of print]

  • Zuo YY Veldhuizen RAW Neumann AW Petersen NO Possmayer F. Current perspectives in pulmonary surfactant - inhibition enhacement and evaluation. Biochim Biophys Acta 2008; 1778: 1947 - 77.

  • Lachman B Robertson B Vogel J. In vivo lung lavage as an experimental model of the respiratory distress syndrome. Acta Anesthesiol Scand 1980; 24(3): 231-6.

  • Calkovska A Mokra D Javorka K Petraskova M Adamicova K. Exogenous surfactant administration by asymmetric high-frequency jet ventilation in experimental respiratory distress syndrome. Croat Med J 2005; 46(2): 209-17.

  • Gooding CA Gregory GA Taber P Wright R. An experimental model for the study of meconium aspiration of the newborn. Radiology 1971; 100: 137- 40.

  • Chen CT Toung TJK Rogers MC. Effect of intra-alveolar meconium on pulmonary surface tension properties. Crit Care Med 1985; 13: 233-6.

  • Auten RL Notter RH Kendig JW Davis JM Shapiro DL. Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991; 87: 101-7.

  • Mokra D Calkovska A Drgova A Javorka M Javorka K. Treatment of experimental meconium aspiration syndrome with surfactant lung lavage and conventional vs.asymmetric high-frequency jet ventilation. Pediatr Pulmonol 2004; 38(4): 285-91.

  • Moses D Holm BA Spitale P Liu M Enhorning G. Inhibition of pulmonary surfactant function by meconium. J Obstet Gynecol 1991; 164: 477-81.

  • Mokra D Mokry J. Meconium aspiration syndrome: from pathomechanisms to treatment. New York: Nova Biomedical Books; 2010.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 348 189 3
PDF Downloads 97 52 0